WOK
WORK Medical Technology Group Ltd.
NASDAQ · Healthcare · Medical - Instruments & Supplies · CN
$1.86
−2.11%Year over year
Reported trailing growth
- Revenue
- -0.2%
- EBITDA
- +22.0%
- EBIT
- +12.5%
- EPS
- —
- Free cash flow
- +57.4%
- Operating cash flow
- +77.0%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -20.6%
- EBITDA
- -58.4%
- EBIT
- +32.5%
- Net income
- +69.3%
- EPS
- -37.1%
- Free cash flow
- +73.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026